Stephens analyst Justin Long raised his price target for CSX to $37 from $32 following Q3 results that came in ahead of Street expectations. The analyst believes near-term set-up remains favorable since CSX has "significantly" improved its operating leverage headed into a period of much easier year over year volume comps. Long reiterates an Overweight rating on the shares.
UBS analyst Thomas Wadewitz lowered the firm's price target on CSX to $44 from $46 and keeps a Buy rating on the shares. CSX's Q1 EPS was modestly above consensus, showing improvement in the Purchased Services and Other expense line and providing positive commentary on their outlook for volumes, the analyst tells investors in a research note. The Q1 report was solid and CSX provided a constructive outlook, UBS contends.
Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGSBank... To see the rest of the story go to thefly.com. See Story Here